OLEPENT, the triterpene-pentapeptide complex with unique cosmeceutical properties created by Sami Labs Limited, emerged the winner in the Fine Chemicals Category. OLEPENT will be launched by Sabinsa later this year to be licensed under exclusivity.
Sabinsa and Sami Labs Founder and Managing Director, Muhammed Majeed, PhD, received the honor at an elite ceremony organized as part of the INDIA CHEM Gujarat 2013 conference held Oct. 24-26 at the Mahatma Gandhi Mandir, Gandhinagar, Gujarat, India. The conference focused on the scientific developments in the areas of Specialty/ Fine/Agro/Personal Care Chemicals/Dyes/Colorants and Pigments.
OLEPENT’s inventive merit was acknowledged by the U.S. Patent Office through U.S. Patent No. 8383594 titled “Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals.” The Karnataka State Innovation Council awarded the inventors of OLEPENT a merit certificate for filing a corresponding Indian Patent application.
“I am honored to accept this award on behalf of Sami Labs Limited in the area of cosmeceutical peptides. The product is the result of years of research combining the strengths of this group in natural products and peptides,” said Dr. Majeed. “OLEPENT is a breakthrough commercial cosmeceutical peptide that is stable, better absorbed into the skin and has proven cosmeceutical properties. The Sami/Sabinsa group continues to deliver new products in the areas of nutrition and cosmetics through constant innovation."